by Mike Frick
Treatment Action Group, October 2016
Despite a critical shortage of resources, scientists have managed to make significant advances against TB over the last five years. This demonstrates that TB research provides a good return on investment, but investment remains too low to unlock the transformational innovations in prevention, diagnosis, and treatment needed by people with TB and those that care for them. Turning this declining trend around will require increased political commitment from all countries but especially from leaders of the BRICS countries (Brazil, Russia, India, China, and South Africa), which bear the greatest TB burden.